CAMK2G and hypertrophy: Lu Y et al. found that transfection of cardiomyocytes with active CaMKII can cause activation of ERK and participate in activation of the foetal cardiac hypertrophy gene program; furthermore, they found that the CaMKII inhibitor KN93 can inhibit the activation of ERK1 induced by endothelin-1 [16].